1Y RSI is falling. MFI is in a decline. 5Y RSI is oversold. MFI has topped and falling. ALL RSI is reaching oversold. MFI is at a bottom. Prediction: This has another drop and once the RSI has bottomed on some of the timeframes it should be ready to fill the gap up around $8. For my educational purpose, not to be used as financial advice.
hit and run, fill the gap today or next week, strong indicators, incoming news
Stock screener showed PMCB as 2nd biggest pre-market gainer, but unlyike VRPX it did not stop at the pre-market high but continued trading higher. Aiming for a 10$ target or higher... Anyway a low risk / high reward play...
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States.